Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Henry ScheinHSIC -0.62%80 3-Year Share Buyback Ratio is 4.20 as of Jun. 2026, which is 1300% above its 10-year median of 0.30. GuruFocus rates HSIC with a GF Score™ of 80/100 and a GF Value™ of $85.60 (Fairly Valued). The stock has 9 warning signs investors should review. Among 70 Medical Distribution companies, Henry Schein ranks better than 94.29% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Henry Schein's current 3-Year Share Buyback Ratio was 4.20%.
The historical rank and industry rank for Henry Schein's 3-Year Share Buyback Ratio or its related term are showing as below:
HSIC'
s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -30 Med: 0.3 Max: 4.2
Current: 4.2
During the past 13 years, Henry Schein's highest 3-Year Share Buyback Ratio was 4.20%. The lowest was -30.00%. And the median was 0.30%.
HSIC's 3-Year Share Buyback Ratio is ranked better than 94.29% of 70
companies
in the Medical Distribution industry
Industry Median: -0.5
vs HSIC: 4.20
Henry Schein (NAS:HSIC) 3-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Henry Schein 3-Year Share Buyback Ratio Related Terms
HSIC vs AHG, ACH, FOCL: 3-Year Share Buyback Ratio Comparison
For the Medical Distribution subindustry, Henry Schein's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Henry Schein 3-Year Share Buyback Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Henry Schein's 3-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Henry Schein's 3-Year Share Buyback Ratio falls into.
Henry Schein 3-Year Share Buyback Ratio Calculation
This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Share Buyback Ratio of 4.20 mean?
Henry Schein (HSIC) has a 3-Year Share Buyback Ratio of 4.20 as of Jun. 2026. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Henry Schein and its competitors. This is 1300% above median its historical median of 0.30. According to the industry distribution chart, Henry Schein ranks #4 out of 70 companies in the Medical Distribution industry, placing it in the top 5.7%.
Is Henry Schein's 3-Year Share Buyback Ratio too high?
Henry Schein's current 3-Year Share Buyback Ratio of 4.20 is 1300% above median its 10-year median of 0.30. Based on the distribution chart, Henry Schein ranks #4 out of 70 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Henry Schein has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Henry Schein's 3-Year Share Buyback Ratio compare to AHG and ACH?
According to the Medical Distribution industry distribution chart, Henry Schein ranks #4 out of 70 companies for 3-Year Share Buyback Ratio. This places Henry Schein in the top 6% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Share Buyback Ratio for a Medical Distribution company?
A good 3-Year Share Buyback Ratio depends on the Medical Distribution industry context. However, 3-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Share Buyback Ratio mean?
A high 3-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Henry Schein and its competitors. Henry Schein's current 3-Year Share Buyback Ratio is 4.20, which is 1300% above median its own 10-year median of 0.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Henry Schein stock overvalued right now?
Based on GuruFocus' analysis, Henry Schein (HSIC) is currently considered Fairly Valued. The stock's GF Value™ is $85.60, compared to a current price of $88.74 — trading 3.7% above its estimated fair value. The current 3-Year Share Buyback Ratio is 4.20, which is 1300% above median its 10-year median of 0.30. Henry Schein's overall GF Score™ is 80/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Share Buyback Ratio calculated?
3-Year Share Buyback Ratio is calculated from a company's financial statements. For Henry Schein (HSIC), the current 3-Year Share Buyback Ratio is 4.20 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Henry Schein (HSIC) Overvalued in 2026?
Based on GuruFocus' analysis, Henry Schein stock appears to be overvalued.
The current stock price of $88.74 is trading 3.7% above its estimated GF Value™ of $85.60.
GuruFocus considers Henry Schein to be Fairly Valued.
Key valuation signals for HSIC:
3-Year Share Buyback Ratio: 4.20 (1300% above median its 10-year median of 0.30)
GF Value™: $85.60 vs. price of $88.74 (3.7% above fair value)
No single metric tells the full story. See the HSIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.
80GF Score
Get the complete analysis for HSIC
3-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HSIC has been successfully added to your 
